Do analysts prefer HCM or ITH?

Ithaca Energy has a consensus target price of GBX 205, indicating a potential downside of 13.06%. Given Ithaca Energy's stronger consensus rating and higher probable upside, analysts plainly believe Ithaca Energy is more favorable than HUTCHMED. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HUTCHMED 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Ithaca Energy 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has stronger earnings and valuation, HCM or ITH?

Ithaca Energy has higher revenue and earnings than HUTCHMED. Ithaca Energy is trading at a lower price-to-earnings ratio than HUTCHMED, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HUTCHMED £548.51M 2.74 -£52.98M £53.00 3.30 Ithaca Energy £2.95B 1.32 £230.29M -£5.10 N/A

Which has preferable earnings and valuation, HCM or INDV?

Indivior has higher revenue and earnings than HUTCHMED. Indivior is trading at a lower price-to-earnings ratio than HUTCHMED, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HUTCHMED £548.51M 2.74 -£52.98M £53.00 3.30 Indivior £1.40B 1.38 -£2.36M -£1.21 N/A

Is HCM or INDV more profitable?

HUTCHMED has a net margin of 104.77% compared to Indivior's net margin of 14.30%. HUTCHMED's return on equity of 41.38% beat Indivior's return on equity. Company Net Margins Return on Equity Return on Assets HUTCHMED 104.77% 41.38% -5.90% Indivior 14.30% -41.70% 2.37%

Do analysts prefer HCM or GRI?

Grainger has a consensus price target of GBX 225.60, suggesting a potential upside of 48.71%. Given Grainger's stronger consensus rating and higher probable upside, analysts plainly believe Grainger is more favorable than HUTCHMED. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HUTCHMED 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Grainger 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80

Which has preferable earnings and valuation, HCM or GRI?

Grainger has lower revenue, but higher earnings than HUTCHMED. HUTCHMED is trading at a lower price-to-earnings ratio than Grainger, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HUTCHMED £548.51M 2.74 -£52.98M £53.00 3.30 Grainger £238.20M 4.71 -£1.11M £27.30 5.56

Is HCM or GRI more profitable?

HUTCHMED has a net margin of 104.77% compared to Grainger's net margin of 54.91%. HUTCHMED's return on equity of 41.38% beat Grainger's return on equity. Company Net Margins Return on Equity Return on Assets HUTCHMED 104.77% 41.38% -5.90% Grainger 54.91% 6.53% 2.14%

HUTCHMED (HCM) Competitors

GBX 175 +1.00 (+0.57%)

As of 11:58 AM Eastern

Compare

HCM vs. ITH, SOPH, INDV, GRI, and SLS

Should you buy HUTCHMED stock or one of its competitors? MarketBeat compares HUTCHMED with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with HUTCHMED include Ithaca Energy (ITH), Sophos Group plc (SOPH.L) (SOPH), Indivior (INDV), Grainger (GRI), and Standard Life UK Smaller Companies Trust (SLS). These companies are all part of the "pharmaceutical products" industry.

How does HUTCHMED compare to Ithaca Energy?

HUTCHMED (LON:HCM) and Ithaca Energy (LON:ITH) are both pharmaceutical products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership.

Ithaca Energy has higher revenue and earnings than HUTCHMED. Ithaca Energy is trading at a lower price-to-earnings ratio than HUTCHMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HUTCHMED	£548.51M	2.74	-£52.98M	£53.00	3.30
Ithaca Energy	£2.95B	1.32	£230.29M	-£5.10	N/A

HUTCHMED has a net margin of 104.77% compared to Ithaca Energy's net margin of 7.53%. HUTCHMED's return on equity of 41.38% beat Ithaca Energy's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HUTCHMED	104.77%	41.38%	-5.90%
Ithaca Energy	7.53%	9.33%	0.18%

20.4% of HUTCHMED shares are owned by institutional investors. Comparatively, 3.6% of Ithaca Energy shares are owned by institutional investors. 2.8% of HUTCHMED shares are owned by company insiders. Comparatively, 0.2% of Ithaca Energy shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

HUTCHMED has a beta of 0.453, meaning that its stock price is 55% less volatile than the broader market. Comparatively, Ithaca Energy has a beta of 0.353, meaning that its stock price is 65% less volatile than the broader market.

In the previous week, Ithaca Energy had 5 more articles in the media than HUTCHMED. MarketBeat recorded 5 mentions for Ithaca Energy and 0 mentions for HUTCHMED. Ithaca Energy's average media sentiment score of 0.91 beat HUTCHMED's score of 0.00 indicating that Ithaca Energy is being referred to more favorably in the news media.

Company	Overall Sentiment
HUTCHMED	Neutral
Ithaca Energy	Positive

Ithaca Energy has a consensus target price of GBX 205, indicating a potential downside of 13.06%. Given Ithaca Energy's stronger consensus rating and higher probable upside, analysts plainly believe Ithaca Energy is more favorable than HUTCHMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HUTCHMED	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Ithaca Energy	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

HUTCHMED and Ithaca Energy tied by winning 8 of the 16 factors compared between the two stocks.

How does HUTCHMED compare to Sophos Group plc (SOPH.L)?

HUTCHMED (LON:HCM) and Sophos Group plc (SOPH.L) (LON:SOPH) are both pharmaceutical products companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability.

In the previous week, HUTCHMED's average media sentiment score of 0.00 equaled Sophos Group plc (SOPH.L)'saverage media sentiment score.

Company	Overall Sentiment
HUTCHMED	Neutral
Sophos Group plc (SOPH.L)	Neutral

Sophos Group plc (SOPH.L) has higher revenue and earnings than HUTCHMED. Sophos Group plc (SOPH.L) is trading at a lower price-to-earnings ratio than HUTCHMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HUTCHMED	£548.51M	2.74	-£52.98M	£53.00	3.30
Sophos Group plc (SOPH.L)	£726.90M	0.00	N/A	£1.70	N/A

20.4% of HUTCHMED shares are held by institutional investors. 2.8% of HUTCHMED shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

HUTCHMED has a net margin of 104.77% compared to Sophos Group plc (SOPH.L)'s net margin of 0.00%. HUTCHMED's return on equity of 41.38% beat Sophos Group plc (SOPH.L)'s return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HUTCHMED	104.77%	41.38%	-5.90%
Sophos Group plc (SOPH.L)	N/A	N/A	N/A

Summary

HUTCHMED beats Sophos Group plc (SOPH.L) on 5 of the 8 factors compared between the two stocks.

How does HUTCHMED compare to Indivior?

HUTCHMED (LON:HCM) and Indivior (LON:INDV) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership.

HUTCHMED has a beta of 0.453, suggesting that its stock price is 55% less volatile than the broader market. Comparatively, Indivior has a beta of 0.19, suggesting that its stock price is 81% less volatile than the broader market.

Indivior has higher revenue and earnings than HUTCHMED. Indivior is trading at a lower price-to-earnings ratio than HUTCHMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HUTCHMED	£548.51M	2.74	-£52.98M	£53.00	3.30
Indivior	£1.40B	1.38	-£2.36M	-£1.21	N/A

HUTCHMED has a net margin of 104.77% compared to Indivior's net margin of 14.30%. HUTCHMED's return on equity of 41.38% beat Indivior's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HUTCHMED	104.77%	41.38%	-5.90%
Indivior	14.30%	-41.70%	2.37%

In the previous week, Indivior had 1 more articles in the media than HUTCHMED. MarketBeat recorded 1 mentions for Indivior and 0 mentions for HUTCHMED. HUTCHMED's average media sentiment score of 0.00 equaled Indivior'saverage media sentiment score.

Company	Overall Sentiment
HUTCHMED	Neutral
Indivior	Neutral

20.4% of HUTCHMED shares are owned by institutional investors. Comparatively, 86.0% of Indivior shares are owned by institutional investors. 2.8% of HUTCHMED shares are owned by insiders. Comparatively, 3.4% of Indivior shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

HUTCHMED and Indivior tied by winning 6 of the 12 factors compared between the two stocks.

How does HUTCHMED compare to Grainger?

HUTCHMED (LON:HCM) and Grainger (LON:GRI) are both small-cap pharmaceutical products companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.

HUTCHMED has a net margin of 104.77% compared to Grainger's net margin of 54.91%. HUTCHMED's return on equity of 41.38% beat Grainger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HUTCHMED	104.77%	41.38%	-5.90%
Grainger	54.91%	6.53%	2.14%

In the previous week, HUTCHMED's average media sentiment score of 0.00 beat Grainger's score of -1.00 indicating that HUTCHMED is being referred to more favorably in the media.

Company	Overall Sentiment
HUTCHMED	Neutral
Grainger	Negative

Grainger has a consensus price target of GBX 225.60, suggesting a potential upside of 48.71%. Given Grainger's stronger consensus rating and higher probable upside, analysts plainly believe Grainger is more favorable than HUTCHMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HUTCHMED	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Grainger	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80

Grainger has lower revenue, but higher earnings than HUTCHMED. HUTCHMED is trading at a lower price-to-earnings ratio than Grainger, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HUTCHMED	£548.51M	2.74	-£52.98M	£53.00	3.30
Grainger	£238.20M	4.71	-£1.11M	£27.30	5.56

20.4% of HUTCHMED shares are owned by institutional investors. Comparatively, 48.3% of Grainger shares are owned by institutional investors. 2.8% of HUTCHMED shares are owned by company insiders. Comparatively, 1.5% of Grainger shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

HUTCHMED has a beta of 0.453, meaning that its stock price is 55% less volatile than the broader market. Comparatively, Grainger has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market.

Summary

Grainger beats HUTCHMED on 9 of the 15 factors compared between the two stocks.

How does HUTCHMED compare to Standard Life UK Smaller Companies Trust?

HUTCHMED (LON:HCM) and Standard Life UK Smaller Companies Trust (LON:SLS) are both small-cap pharmaceutical products companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, earnings, dividends and profitability.

Standard Life UK Smaller Companies Trust has lower revenue, but higher earnings than HUTCHMED. Standard Life UK Smaller Companies Trust is trading at a lower price-to-earnings ratio than HUTCHMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HUTCHMED	£548.51M	2.74	-£52.98M	£53.00	3.30
Standard Life UK Smaller Companies Trust	£222.48M	0.00	N/A	£217.40	N/A

HUTCHMED has a net margin of 104.77% compared to Standard Life UK Smaller Companies Trust's net margin of 0.00%. HUTCHMED's return on equity of 41.38% beat Standard Life UK Smaller Companies Trust's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HUTCHMED	104.77%	41.38%	-5.90%
Standard Life UK Smaller Companies Trust	N/A	N/A	N/A

In the previous week, HUTCHMED's average media sentiment score of 0.00 equaled Standard Life UK Smaller Companies Trust'saverage media sentiment score.

Company	Overall Sentiment
HUTCHMED	Neutral
Standard Life UK Smaller Companies Trust	Neutral

20.4% of HUTCHMED shares are held by institutional investors. 2.8% of HUTCHMED shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

HUTCHMED beats Standard Life UK Smaller Companies Trust on 5 of the 8 factors compared between the two stocks.

Get HUTCHMED News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HCM vs. The Competition

Export

Metric	HUTCHMED	Drug Manufacturers Industry	Medical Sector	LON Exchange
Market Cap	£1.50B	£2.43B	£6.25B	£2.78B
Dividend Yield	4.63%	2.94%	2.69%	6.13%
P/E Ratio	3.30	5.21	22.28	364.74
Price / Sales	2.74	1,776.16	581.86	87,565.33
Price / Cash	2.49	10.18	42.31	27.85
Price / Book	2.00	10.85	9.84	7.71
Net Income	-£52.98M	£20.70B	£3.57B	£5.89B
7 Day Performance	0.41%	-0.29%	-1.15%	0.07%
1 Month Performance	-10.26%	4.01%	3.85%	3.26%
1 Year Performance	-19.35%	15.66%	27.43%	75.52%

HUTCHMED Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HCM HUTCHMED	N/A	GBX 175 +0.6%	N/A	-13.9%	£1.50B	£548.51M	3.30	1,760	News Coverage Positive News Gap Up
ITH Ithaca Energy	1.6769 of 5 stars	GBX 249.60 -2.6%	GBX 205 -17.9%	+60.1%	£4.23B	£2.95B	N/A	220	News Coverage
SOPH Sophos Group plc (SOPH.L)	N/A	N/A	N/A	N/A	£2.99B	£726.90M	341.41	520
INDV Indivior	N/A	GBX 1,238 +1.6%	N/A	+33.9%	£1.93B	£1.40B	N/A	1,000	News Coverage Gap Up High Trading Volume
GRI Grainger	4.6586 of 5 stars	GBX 153.60 +0.3%	GBX 237.20 +54.4%	-29.6%	£1.13B	£238.20M	5.63	372

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:HCM) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

HUTCHMED (HCM) Competitors

HCM vs. ITH, SOPH, INDV, GRI, and SLS

How does HUTCHMED compare to Ithaca Energy?

Summary

How does HUTCHMED compare to Sophos Group plc (SOPH.L)?

Summary

How does HUTCHMED compare to Indivior?

Summary

How does HUTCHMED compare to Grainger?

Summary

How does HUTCHMED compare to Standard Life UK Smaller Companies Trust?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HCM vs. The Competition

HUTCHMED Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

HUTCHMED (HCM) Competitors

HCM vs. ITH, SOPH, INDV, GRI, and SLS

How does HUTCHMED compare to Ithaca Energy?

Which has stronger earnings and valuation, HCM or ITH?

Is HCM or ITH more profitable?

Do institutionals & insiders have more ownership in HCM or ITH?

Which has more risk & volatility, HCM or ITH?

Does the media favor HCM or ITH?

Do analysts prefer HCM or ITH?

Summary

How does HUTCHMED compare to Sophos Group plc (SOPH.L)?

Does the media prefer HCM or SOPH?

Which has higher valuation and earnings, HCM or SOPH?

Do insiders and institutionals believe in HCM or SOPH?

Is HCM or SOPH more profitable?

Summary

How does HUTCHMED compare to Indivior?

Which has more volatility and risk, HCM or INDV?

Which has preferable earnings and valuation, HCM or INDV?

Is HCM or INDV more profitable?

Does the media favor HCM or INDV?

Do institutionals & insiders believe in HCM or INDV?

Summary

How does HUTCHMED compare to Grainger?

Is HCM or GRI more profitable?

Does the media favor HCM or GRI?

Do analysts prefer HCM or GRI?

Which has preferable earnings and valuation, HCM or GRI?

Do institutionals and insiders hold more shares of HCM or GRI?

Which has more risk and volatility, HCM or GRI?

Summary

How does HUTCHMED compare to Standard Life UK Smaller Companies Trust?

Which has stronger valuation & earnings, HCM or SLS?

Is HCM or SLS more profitable?

Does the media refer more to HCM or SLS?

Do institutionals and insiders believe in HCM or SLS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HCM vs. The Competition

HUTCHMED Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools